ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+9.51%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$550M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| 1 |
Microsoft
MSFT
|
$111M |
| 2 |
VF Corp
VFC
|
$69M |
| 3 |
Amazon
AMZN
|
$60.3M |
| 4 |
Stanley Black & Decker
SWK
|
$58M |
| 5 |
West Pharmaceutical
WST
|
$42.9M |
Top Sells
| 1 |
Target
TGT
|
$158M |
| 2 |
Apple
AAPL
|
$118M |
| 3 |
Cardinal Health
CAH
|
$44.3M |
| 4 |
Fortinet
FTNT
|
$39.6M |
| 5 |
Exxon Mobil
XOM
|
$33.1M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.19% |
| 3 | Consumer Staples | 11.65% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Bionano Genomics
BNGO
$18.7M
| $56.2K | ﹤0.01% |
64
+10
| +19% | +$8.78K |
|
|
BHIL
1727
DELISTED
Benson Hill, Inc.
BHIL
| $56.2K | ﹤0.01% |
629
+90
| +17% | +$8.04K |
|
|
CTEV
1728
Claritev Corporation
CTEV
$1.15B
| $55.9K | ﹤0.01% |
1,216
+175
| +17% | +$8.05K |
|
1729
TETRA Technologies
TTI
$625M
| $55.4K | ﹤0.01% |
16,018
+2,296
| +17% | +$7.94K |
|
1730
OraSure Technologies
OSUR
$236M
| $54.7K | ﹤0.01% |
+11,355
| New | +$54.7K |
|
|
HLTH
1731
DELISTED
Cue Health Inc. Common Stock
HLTH
| $54.6K | ﹤0.01% |
26,369
+14,366
| +120% | +$29.7K |
|
1732
Unisys
UIS
$277M
| $53.7K | ﹤0.01% |
+10,499
| New | +$53.7K |
|
1733
IonQ
IONQ
$12.4B
| $52.8K | ﹤0.01% |
15,310
+2,211
| +17% | +$7.63K |
|
|
SRNE
1734
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $52.6K | ﹤0.01% |
59,354
+17,443
| +42% | +$15.5K |
|
1735
Marathon Digital Holdings
MARA
$5.63B
| $51.5K | ﹤0.01% |
15,064
+2,832
| +23% | +$9.69K |
|
1736
Lexicon Pharmaceuticals
LXRX
$396M
| $50.3K | ﹤0.01% |
26,324
+1,699
| +7% | +$3.25K |
|
1737
Clear Channel Outdoor Holdings
CCO
$656M
| $49.8K | ﹤0.01% |
47,458
+6,801
| +17% | +$7.14K |
|
|
SLGC
1738
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $48.3K | ﹤0.01% |
19,257
+2,761
| +17% | +$6.93K |
|
1739
Arlo Technologies
ARLO
$1.89B
| $48.3K | ﹤0.01% |
13,752
+1,795
| +15% | +$6.3K |
|
1740
Gevo
GEVO
$404M
| $48.1K | ﹤0.01% |
25,328
+3,629
| +17% | +$6.9K |
|
1741
Douglas Elliman
DOUG
$257M
| $47.6K | ﹤0.01% |
12,277
+1,600
| +15% | +$6.2K |
|
|
DM
1742
DELISTED
Desktop Metal, Inc.
DM
| $46.9K | ﹤0.01% |
3,450
+535
| +18% | +$7.28K |
|
1743
Gannett
GCI
$629M
| $46.3K | ﹤0.01% |
22,789
+3,066
| +16% | +$6.22K |
|
1744
Clover Health Investments
CLOV
$1.41B
| $46.2K | ﹤0.01% |
49,708
+7,124
| +17% | +$6.62K |
|
|
NPKI
1745
NPK International Inc.
NPKI
$887M
| $46.1K | ﹤0.01% |
+11,099
| New | +$46.1K |
|
1746
Precigen
PGEN
$1.3B
| $45.9K | ﹤0.01% |
30,203
+1,566
| +5% | +$2.38K |
|
1747
Ocular Therapeutix
OCUL
$2.37B
| $45.8K | ﹤0.01% |
16,284
+1,298
| +9% | +$3.65K |
|
|
ROVR
1748
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $44.2K | ﹤0.01% |
12,042
+1,819
| +18% | +$6.68K |
|
1749
Ardelyx
ARDX
$1.57B
| $44.2K | ﹤0.01% |
+15,504
| New | +$44.2K |
|
1750
Generation Bio
GBIO
$40.3M
| $43.6K | ﹤0.01% |
1,110
+85
| +8% | +$3.34K |
|